Effects of parathyroid hormone and 1,25(OH2)D3on protein glycation in moderate uraemia?

Nephron

Volumn 74, Issue 2, 1996, Pages 295-300

  Lamb, E J ^a   Fluck, R J ^b   Venton, T R ^b   Woodhead, J S ^c   Raine, A E G ^b   Dawnay, A B S J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Chronic renal failure; Fructosamine; Glucose intolerance; Glycated albumin; Parathyroid hormone; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM ION; FRUCTOSAMINE; GLYCOSYLATED ALBUMIN; PARATHYROID HORMONE; PROTEIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; ORAL DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SECONDARY HYPERPARATHYROIDISM; UREMIA;

CALCITRIOL; CALCIUM; FRUCTOSAMINE; GLYCOSYLATION; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; REFERENCE VALUES; REGRESSION ANALYSIS; SERUM ALBUMIN; TIME FACTORS; UREMIA;

EID: 0029794504     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189324     Document Type: Article

References (28)

1. Wcstervclt FB, Schreiner GE: The carbohydrate intolerance of urcmic patients. Ann Intern Med 1962:57:266-276.
2. Hager SR: Insulin resistance of uremia. Am J Kidney Dis 1989;14:272-276.
3. Mayer TK, Freedman ZR: Protein glycosyla-tion in diabetes mellitus: A review of laboratory measurements and of their clinical utility. ClinChim Acta 1983;127:147-184.
4. Morgan LJ. Marcnah CB. Morgan AG. Burden RP John WG: Glycated haemoglobin and fruc-tosamine in non-diabetic subjects with chronic renal latlure. Nephrol Dial I ransplant 1990:5: 868-873.
5. Lamb E. Venton TR. Cattcll WR. Dawnay ABSTJ: Serum glycated albumin and fruc-tosamine in renal dialysis patients. Nephron 1993;64:82-88.
6. Mak RHK. DeFronzo RA: Glucose and insulin metabolism in uremia. Nephron 1992:61:377-382.
7. Mak RHK: Insulin secretion in uremia: Effect of parathyroid hormone and vitamin D metabolites. Kidney Int I989:36(suppl 27):227-230.
8. Wilson L. Felsenfeld A, Dresner MK. Llaeh F: Altered divalent ion metabolism in early renal failure: Role of l,25-(OH)2D3. Kidney Int 1985:27:565-573.
9. Akmal M. Massry SG. Goldstein DA. Fanti P. Weisz A. DeFronzo RA: Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 1985:75:1037-1044.
10. Fadda GZ. Akmal M. Premdas FH. Lipson LG. Massry SG: Insulin release from pancreatic islets: Effects of CRF and excess PTH. Kidney Int 1988:33:1066-1072.
11. Mak RHK. Bettinclli A, Turner C. Haycock GB. Chantler C: The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Mctab 1985:60:229-233.
12. Roth J. Bonner-Wcir S. Norman AW. Orci L: Immunocytochcmistry of vitamin D-depen-denl calcium binding protein in chick pancreas: Exclusive localization in Tcells. Endocrinology 1982:110:2216-2218.
13. Clark SA, Stumpf WE. Madhabanada S: Effect of 1.25-dihydroxyvitamin D-, on insulin secretion. Diabetes 1981:30:382-386.
14. Quesada JM. Martm-Malo A. Santiago J: Effect of calcitriol on insulin secretion in uraemia. Nephrol Dial Transplant 1990:5:1013-1017.
15. Turk S, Ycksam M, Tamer N, Gurbilck M. Erdogan Y. Erkul I: Effect of 1,25(OH)iD3 treatment on glucose intolerance in uraemia. Nephrol Dial Transplant 1992:7:1207-1212.
16. Silver AC. Lamb E. Cattell WR. Dawnay ABSTJ: Investigation and validation of the affinity chromatography method for measuring glycated albumin in scrum and urine. Clin ChimActa 1991;202:11-22.
17. Lamb E. Mainwaring-Burton R. Dawnay ABSTJ: Effect of protein concentration on the formation of glycated albumin and fructos-amine. Clin Client 1991:37:2138-2139.
18. Lamb E. Dawnay ABStJ: Glycated haemoglobin measurement in uraemic patients. Ann Clin Biochem 1992,29:118-119.
19. Peters T: Scrum albumin: in Putnam FW (ed): The Plasma Proteins. New York. Academic Press. 1975. pp 133-181.
20. c and glyco-syl-albumin levels during recovery from diabetic ketoacidosis and non-acidotic coma. Diabc-tologia 1981:21:211-215.
21. Leipcr JM. Talwar D. Robb DA. Lunan CB. MacC'uish AC: Glycosylated albumin and glycosylated proteins: rapidly changing indices of glycacmia in diabetic pregnancy. Q J Med 1985:218:225-231.
22. Salusky IB. Goodman WG. Horst R. Segre GV. Kim L. Norris KC. Adams JS, Holloway M, Fine RN. Coburn JW: Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients. Am J Kidney Dis 1990:16:126-132.
23. Mak RHK: Intravenous 1,25-dihvdroxychole-calciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992:41:1049- 1054.
24. Turner C. Compston J. Mak RHK. Vedi S, Mellish RWE, Haycock GB. Chantler C: Bone turnover and 1.25-dihydroxycholecalcifcrol during treatment with phosphate binders. Kidney Int 1988:33:989-995.
25. Mak RHK. Turner C. Haycock GB. Chantler C: Secondary hyperparathyroidism and glucose intolerance in children with uremia. Kidney Int 1983;24(suppl): 128-133.
26. Mak RHK: Carbohydrate metabolism in uraemia. Pediatr Nephrol 1989:3:201-208.
27. Cade C. Norman AW: Rapid normalization/ stimulation by 1.25-dihydroxyvitamin D; of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 1987: 120:1490-1497.
28. Allegra V, Mengozzi G. Martimbianco L. Va-sile A: Glucose-induced insulin secretion in uraemia: Effects of aminophyllinc infusion and glucose loads. Kidney Int 1990:38:1146-1150.